New Key Statistics Module, Z-Score and F-Score
NAS:DNTH Key Ratios
| Market Cap $ M | 740.19 |
| Enterprise Value $ M | 363.65 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.99 |
| Price/Sales | 83.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -5.03 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.81 |
| EV-to-EBITDA | -7.85 |
| PEG | -- |
| Shares Outstanding M | 29.35 |
| Net Margin (%) | -1,732.77 |
| Operating Margin % | -2,064.70 |
| Pre-tax Margin (%) | -1,732.77 |
| Quick Ratio | 42.52 |
| Current Ratio | 42.52 |
| ROA % (ttm) | -15.54 |
| ROE % (ttm) | -16.28 |
| ROIC % (ttm) | -809.16 |
| Dividend Yield % | -- |
| Altman Z-Score | 45.83 |
DNTH Number of Guru Trades
DNTH Volume of Guru Trades
Gurus Latest Trades with NAS:DNTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DNTH is held by these investors
Total 1
Dianthus Therapeutics Inc Insider Transactions
No Available Data
News about NAS:DNTH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers